Germany · Series B startup

Who invested in Aignostics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AI

Funding summaryUpdated 26 Oct 2026

$34Mraised across 1 round since 2024, from 1 source

Latest round
Series B, $34MOct 2024
Investors
4
See who backed them

The rounds

  1. Oct 2024

Founders and team

From Aignostics's own website: 8 on the team.

  • Montserrat CarrascoVP of Finance & Organization
  • Dr. Julika Ribbat-IdelPrincipal Pathologist
  • Emmanuel BlinChairman of the Board
  • Frank MünzingerQuality Manager
  • Jonathan StreibelSenior Machine Learning Software Engineer
  • Natalie BattySenior Regulatory Affairs Specialist
  • Srishti Munjal MehtaScientific Program Manager
  • Timo HaschlerSenior Scientific Program Manager

AdvisersProfessor Frederick KlauschenProfessor Klaus-Robert Müller

Everyone who backed them

Wellington PartnersVC firm1round
Mayo ClinicInvestment firm1round
IBB VenturesGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Aignostics

Who invested in Aignostics?

Aignostics's investors include Wellington Partners, Mayo Clinic, IBB Ventures and Boehringer Ingelheim Venture Fund.

How much has Aignostics raised?

Aignostics has raised $34M across 1 round since 2024.

When did Aignostics last raise?

Aignostics's most recent round was a Series B of $34M in Oct 2024.

What was Aignostics's biggest round?

Its most recent round, $34M in Oct 2024, is also its largest on record.

Who backed Aignostics first?

Aignostics's first round on record, in Oct 2024, was backed by Wellington Partners, Mayo Clinic and IBB Ventures and 1 others.

What stage is Aignostics at?

Aignostics's latest named round is a Series B, in Oct 2024.

Where is Aignostics based?

Aignostics is based in Germany.

Companies like Aignostics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.